A two‐step electrochemical biosensor based on Tetrazyme for the detection of fibrin
Biotechnology and Applied Biochemistry · 2024
DOI: 10.1002/bab.2531 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2024. Verfasst von Jiayi Jiang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Devices, Shanghai University of Medicine & Health Sciences, Shanghai, China. Hauptthemen laut MEDLINE: Biosensing Techniques. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Shanghai Science and Technology Commission, Shanghai Municipal Health Commission, Shanghai University of Medicine & Health Sciences.
Abstract (Originalsprache)
In this study, an electrochemical biosensor was constructed for the detection of fibrin, specifically by a simple two‐step approach, with a novel artificial enzyme (Tetrazyme) based on the DNA tetrahedral framework as signal probe. The multichannel screen‐printed electrode with the activated surface cannot only remove some biological impurities, but also serve as a carrier to immobilize a large number of antigen proteins. The DNA tetrahedral nanostructure was employed to ensure the high sensitivity of the probe for biological analysis. The hemin was chimeric into the G‐quadruplex to constitute the complex with peroxidase catalytic activity (hemin/G4‐DNAzyme), subsequently, Tetrazyme was formed through combining of this complex and DNA tetrahedral nucleic acid framework. The artificial enzyme signal probe formed by the covalent combination of the homing peptide (Cys‐Arg‐Glu‐Lys‐Ala, CREKA), which is the aptamer of fibrin and the new artificial enzyme is fixed on the surface of the multichannel carbon electrode by CREKA‐specific recognition, so as to realize the sensitive detection of fibrin. The feasibility of sensing platform was validated by cyclic voltammetry (CV) and amperometric i – t curve (IT) methods. Effects of Tetrazyme concentration, CREKA concentrations and hybridization time on the sensor were explored. Under the best optimal conditions of 0.6 μmol/L Tetrazyme, 80 μmol/L CREKA, and 2.5 h reaction time, the immunosensor had two linear detection ranges, 10–40 nmol/L, with linear regression equation Y = 0.01487 X − 0.011 ( R 2 = 0.992), and 50–100 nmol/L, with linear regression equation Y = 0.00137 X + 0.6405 ( R 2 = 0.998), the detection limit was 9.4 nmol/L, S / N ≥ 3. The biosensor could provide a new method with great potential for the detection of fibrin with good selectivity, stability, and reproducibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Devices, Shanghai University of Medicine & Health Sciences, Shanghai, China.
- Department of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China.
- Department of Graduate, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Dongdong Zeng
Förderung
- Shanghai Science and Technology Commission
- Shanghai Municipal Health Commission
- Shanghai University of Medicine & Health Sciences
Zitieren
APA
Jiang, J., Wang, B., Luo, L., Ying, N., Shi, G., Zhang, M., Su, H., & Zeng, D. (2024). A two‐step electrochemical biosensor based on Tetrazyme for the detection of fibrin. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2531
Vancouver
Jiang J, Wang B, Luo L, Ying N, Shi G, Zhang M, et al. A two‐step electrochemical biosensor based on Tetrazyme for the detection of fibrin. Biotechnology and Applied Biochemistry. 2024. doi:10.1002/bab.2531
BibTeX
@article{Jiang2024,
author = {Jiang, Jiayi and Wang, Bin and Luo, Linghuan and Ying, Na and Shi, Gaofan and Zhang, Mengmeng and Su, Haoyuan and Zeng, Dongdong},
title = {A two‐step electrochemical biosensor based on Tetrazyme for the detection of fibrin},
journal = {Biotechnology and Applied Biochemistry},
year = {2024},
doi = {10.1002/bab.2531}
}
EUVIMED